Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Rumble

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Kidney International|April 1, 1992
Antihypertensive therapy in a model combining spontaneous hypertension with diabetesM E Cooper, J R Rumble, T J Allen, et al.
Journal of Research of the National Institute of Standards and Technology|August 9, 2016
NIST Mechanisms for Disseminating MeasurementsT E Gills, S Dittman, J R Rumble, et al.
The Journal of Clinical Investigation|March 1, 1997
Vascular hypertrophy in experimental diabetes. Role of advanced glycation end productsJ R Rumble, M E Cooper, T Soulis, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 10, 2002
Expression of the slit-diaphragm protein, nephrin, in experimental diabetic nephropathy: differing effects of anti-proteinuric therapiesDarren J Kelly, Petri Aaltonen, Alison J Cox, et al.
Circulation Research|February 10, 2000
Endothelin receptor antagonism ameliorates mast cell infiltration, vascular hypertrophy, and epidermal growth factor expression in experimental diabetesR E Gilbert, J R Rumble, Z Cao, et al.
Circulation Research|January 11, 2000
Diabetes-induced vascular hypertrophy is accompanied by activation of Na(+)-H(+) exchange and prevented by Na(+)-H(+) exchange inhibitionK Jandeleit-Dahm, K M Hannan, C A Farrelly, et al.
Diabetologia|December 29, 2000
Angiotensin converting enzyme inhibition reduces retinal overexpression of vascular endothelial growth factor and hyperpermeability in experimental diabetesR E Gilbert, D J Kelly, A J Cox, et al.
Journal of Hepatology|October 11, 2001
Effect of angiotensin II type 1 receptor blockade on experimental hepatic fibrogenesisG Paizis, R E Gilbert, M E Cooper, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Kidney International|April 1, 1992
Antihypertensive therapy in a model combining spontaneous hypertension with diabetesM E Cooper, J R Rumble, T J Allen, et al.
Journal of Research of the National Institute of Standards and Technology|August 9, 2016
NIST Mechanisms for Disseminating MeasurementsT E Gills, S Dittman, J R Rumble, et al.
The Journal of Clinical Investigation|March 1, 1997
Vascular hypertrophy in experimental diabetes. Role of advanced glycation end productsJ R Rumble, M E Cooper, T Soulis, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 10, 2002
Expression of the slit-diaphragm protein, nephrin, in experimental diabetic nephropathy: differing effects of anti-proteinuric therapiesDarren J Kelly, Petri Aaltonen, Alison J Cox, et al.
Circulation Research|February 10, 2000
Endothelin receptor antagonism ameliorates mast cell infiltration, vascular hypertrophy, and epidermal growth factor expression in experimental diabetesR E Gilbert, J R Rumble, Z Cao, et al.
Circulation Research|January 11, 2000
Diabetes-induced vascular hypertrophy is accompanied by activation of Na(+)-H(+) exchange and prevented by Na(+)-H(+) exchange inhibitionK Jandeleit-Dahm, K M Hannan, C A Farrelly, et al.
Diabetologia|December 29, 2000
Angiotensin converting enzyme inhibition reduces retinal overexpression of vascular endothelial growth factor and hyperpermeability in experimental diabetesR E Gilbert, D J Kelly, A J Cox, et al.
Journal of Hepatology|October 11, 2001
Effect of angiotensin II type 1 receptor blockade on experimental hepatic fibrogenesisG Paizis, R E Gilbert, M E Cooper, et al.
Pageof 2